Chonluten
Status
No approved product. No FDA-approved labeling exists. Not an FDA-approved medicine. Status in Russia and other countries was not verified for this entry.
What it is
A lung-tissue bioregulator peptide with limited published work.
What published research measured
A synthetic short peptide from the Khavinson programme directed at bronchial epithelium and lung tissue, reported by the originating group to have antioxidant and epithelial-protective activity in laboratory models. As with the rest of the synthetic bioregulators, the evidence is confined to that network's own preclinical and observational publications, mostly in Russian, without registered clinical trials or independent replication. This entry does not cite human efficacy or safety data from the peer-reviewed English-language literature.
Source
Khavinson programme preclinical publications
Sources
No linked primary source is on file for this entry yet.
Educational use only, never medical advice. No doses.